Publikationen von Danila Seidel
Alle Typen
Zeitschriftenartikel (11)
2014
Zeitschriftenartikel
4 (2), S. 246 - 257 (2014)
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer. Cancer Discovery 2013
Zeitschriftenartikel
5 (209), 209ra153 (2013)
A genomics-based classification of human lung tumors. Science Translational Medicine 2012
Zeitschriftenartikel
150 (6), S. 1107 - 1120 (2012)
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell
Zeitschriftenartikel
7 (12), e52795 (2012)
High-throughput mutation profiling of primary and metastatic endometrial cancers identifies KRAS, FGFR2 and PIK3CA to be frequently mutated. PLoS ONE
Zeitschriftenartikel
44 (10), S. 1104- - 11xx (2012)
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nature Genetics
Zeitschriftenartikel
109 (42), S. 17034 - 17039 (2012)
A framework for identification of actionable cancer genome dependencies in small cell lung cancer. Proceedings of the National Academy of Sciences of the United States of America 2011
Zeitschriftenartikel
1 (1), S. 78 - 89 (2011)
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discovery
Zeitschriftenartikel
6 (5), S. e19601 - e19601 (2011)
Benchmarking of mutation diagnostics in clinical lung cancer specimens. PLoS ONE 2010
Zeitschriftenartikel
5 (3), S. 407 - 409 (2010)
Osteoblastic response in patients with non-small cell lung cancer with activating EGFR mutations and bone metastases during treatment with EGFR kinase inhibitors. Journal of Thoracic Oncology
Zeitschriftenartikel
2 (62), S. 62ra93 - 62ra93 (2010)
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Science Translational Medicine 2009
Zeitschriftenartikel
4 (9), S. S800 - S800 (2009)
Chemical genomics of RAD001 in non-small cell lung cancer. Journal of Thoracic Oncology